§ Funding Round
Series B funding round for NorthSea Therapeutics raising $40M in January 2020
Series B funding round for NorthSea Therapeutics raising $40M in January 2020
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
Ascendant BioCapital | — | — |
| Organization | — | |
Oscar Slotboom | — | — |
| Organization | — | |
Domain Associates | — | — |
EQT Life Sciences | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
Mission BioCapital | — | — |
| Organization | — | |
Novo Seeds | — | — |
| Angel | maha katabi, phd, cfa |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$149M
Top Valuation
-
NorthSea Therapeutics raised $40M in a Series B round.
The round was announced on 01/01/20.
